Analysen von Emily Field
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.08.23 | Bayer Overweight | Barclays Capital | |
| 08.08.23 | Merck Overweight | Barclays Capital | |
| 07.08.23 | Merck Overweight | Barclays Capital | |
| 25.07.23 | Bayer Overweight | Barclays Capital | |
|
Werbung
|
|||
| 24.07.23 | Bayer Overweight | Barclays Capital | |
| 24.07.23 | Merck Overweight | Barclays Capital | |
| 21.06.23 | Bayer Overweight | Barclays Capital | |
| 06.06.23 | Merck Overweight | Barclays Capital | |
| 05.06.23 | AstraZeneca Overweight | Barclays Capital | |
| 25.05.23 | Bayer Overweight | Barclays Capital | |
| 23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
| 23.05.23 | Sanofi Overweight | Barclays Capital | |
| 15.05.23 | Merck Overweight | Barclays Capital | |
| 12.05.23 | Bayer Overweight | Barclays Capital | |
| 11.05.23 | Merck Overweight | Barclays Capital | |
| 02.05.23 | Merck Overweight | Barclays Capital | |
| 25.04.23 | Bayer Overweight | Barclays Capital | |
| 20.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 14.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 13.04.23 | Merck Overweight | Barclays Capital | |
| 12.04.23 | AstraZeneca Overweight | Barclays Capital | |
| 12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 27.03.23 | Sanofi Overweight | Barclays Capital | |
| 28.02.23 | Bayer Overweight | Barclays Capital | |
| 09.02.23 | Bayer Overweight | Barclays Capital | |
| 25.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 25.01.23 | Roche Overweight | Barclays Capital | |
| 25.01.23 | Bayer Overweight | Barclays Capital | |
| 25.01.23 | Merck Overweight | Barclays Capital | |
| 25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.01.23 | Bayer Overweight | Barclays Capital | |
| 10.01.23 | Bayer Overweight | Barclays Capital | |
| 09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.22 | Merck Overweight | Barclays Capital | |
| 23.12.22 | Roche Overweight | Barclays Capital | |
| 23.12.22 | Bayer Overweight | Barclays Capital | |
| 22.11.22 | Merck Overweight | Barclays Capital | |
| 18.11.22 | Bayer Overweight | Barclays Capital | |
| 15.11.22 | Merck Overweight | Barclays Capital | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
| 14.11.22 | Roche Overweight | Barclays Capital | |
| 10.11.22 | Merck Overweight | Barclays Capital | |